Increased visfatin expression and/or visfatin plasma concentrations have been identified in a variety of chronic inflammatory diseases, including rheumatoid arthritis [9], inflammatory bowel disease [8], and psoriasis [10]. This evidence concerns the gene NAMPT and inflammatory bowel disease.